• 6555 Citations
  • 42 h-Index
1991 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Michele Spina is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles
Non-Hodgkin's Lymphoma Medicine & Life Sciences
HIV Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, Spina, M., Ladetto, M. & Merli, F., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Dacarbazine
Vinblastine
Bleomycin
Hodgkin Disease
Radiotherapy
1 Citation (Scopus)

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Luminari, S., Merli, M., Rattotti, S., Tarantino, V., Marcheselli, L., Cavallo, F., Varettoni, M., Bianchi, B., Merli, F., Tedeschi, A., Cabras, G., Re, F., Visco, C., Torresan Delamain, M., Cencini, E., Spina, M., Ferrero, S., Ferrari, A., Deodato, M., Mannina, D. & 7 others, Annibali, O., Rago, A., Orsucci, L., Defrancesco, I., Frigeni, M., Cesaretti, M. & Arcaini, L., Sep 5 2019, In : Blood. 134, 10, p. 798-801 4 p.

Research output: Contribution to journalArticle

Disease Progression
Lymphoma
Survival
B-Cell Lymphoma
Follicular Lymphoma

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies

Ayed, A. O., Chiappella, A., Pederson, L., Laplant, B. R., Congiu, A. G., Gaidano, G., Spina, M., Re, A., Cavallo, F., Musuraca, G., Macon, W. R., Witzig, T., Vitolo, U. & Nowakowski, G. S., Jun 26 2018, In : Blood Cancer Journal. 8, 7, 5 p., 63.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Central Nervous System
Recurrence
lenalidomide
4 Citations (Scopus)

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies

Ayed, A. O., Chiappella, A., Pederson, L., Laplant, B. R., Congiu, A. G., Gaidano, G., Spina, M., Re, A., Cavallo, F., Musuraca, G., MacOn, W. R., Witzig, T., Vitolo, U. & Nowakowski, G. S., Jul 1 2018, In : Blood Cancer Journal. 8, 7, 63.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Central Nervous System
Recurrence
lenalidomide

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies

Ayed, A. O., Chiappella, A., Pederson, L., Laplant, B. R., Congiu, A. G., Gaidano, G., Spina, M., Re, A., Cavallo, F., Musuraca, G., MacOn, W. R., Witzig, T., Vitolo, U. & Nowakowski, G. S., 2018, In : Blood Cancer Journal. 8, 7

Research output: Contribution to journalArticle